Table 2.
Side effects reported after the first- and second-dose vaccinations.
| Population Characteristics | First Dose (n = 460) | Second Dose (n = 365) | p-value |
|---|---|---|---|
| Fever, n (%) | 44 (9.6) | 17 (4.6) | .007 |
| Myalgia, n (%) | 3 (0.65) | 26 (7.1) | ≤.001 |
| Arm pain at the injection site, n (%) | 374 (81.3) | 91 (24.9) | ≤.001 |
| Headache, n (%) | 12 (2.61) | 7 (1.92) | .642 |
| Fatigue, n (%) | 22 (4.8) | 23 (6.3) | .759 |
| Other symptoms, n (%) | 7 (1.52) | 4 (1.1) | .789 |
| Symptoms duration days, mean, SD (minimum-maximum) | 0.98 ± 0.61 (0–7) | 0.41 ± 0.73 (0–5) | ≤.001 |
SD: Standard Deviation.